Correlation Between Serstech and Xbrane Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Serstech and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Serstech and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Serstech AB and Xbrane Biopharma AB, you can compare the effects of market volatilities on Serstech and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Serstech with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Serstech and Xbrane Biopharma.

Diversification Opportunities for Serstech and Xbrane Biopharma

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Serstech and Xbrane is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Serstech AB and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and Serstech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Serstech AB are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of Serstech i.e., Serstech and Xbrane Biopharma go up and down completely randomly.

Pair Corralation between Serstech and Xbrane Biopharma

Assuming the 90 days trading horizon Serstech AB is expected to generate 0.29 times more return on investment than Xbrane Biopharma. However, Serstech AB is 3.5 times less risky than Xbrane Biopharma. It trades about 0.07 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about -0.02 per unit of risk. If you would invest  59.00  in Serstech AB on August 26, 2024 and sell it today you would earn a total of  66.00  from holding Serstech AB or generate 111.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Serstech AB  vs.  Xbrane Biopharma AB

 Performance 
       Timeline  
Serstech AB 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Serstech AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Serstech may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Xbrane Biopharma 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Xbrane Biopharma AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Xbrane Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Serstech and Xbrane Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Serstech and Xbrane Biopharma

The main advantage of trading using opposite Serstech and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Serstech position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.
The idea behind Serstech AB and Xbrane Biopharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk